The Valley Desk

Clinical trial reportCirculationPublished

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Circulation
Published
Subject terms
Humans; Cardiomyopathy, Hypertrophic; Benzylamines; Uracil; Stroke Volume; Treatment Outcome; Double-Blind Method; Ventricular Function, Left; Time Factors; Adult; Aged; Middle Aged
PubMed ID
39556124
PubMed Central ID
PMC12063683
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal